3 Unstoppable Nasdaq-100 Stocks to Buy Before October Ends

The article presents Monster Beverage, Keurig Dr Pepper and Mondelez as potential consumer-staples opportunities ahead of upcoming earnings, while noting their shares have recently fallen amid high-cost and tech-sector jitters. Monster's overseas sales rose 34.6% last quarter and reached about 46% of total sales; KDP's refreshment sales rose 10% with volume up 6.5%, though it expects 4.1x leverage at end-2026 and U.S. coffee sales fell 3.2%. Mondelez reported positive volume and mix and raised its dividend 4%; risks cited include aluminum costs, KDP debt and Mondelez's brand-investment costs and European recovery.

Analysis

The more investable distinction is earnings quality, not the shared “defensive consumer” label. Mondelēz’s volume recovery is the cleanest near-term test: if it persists without heavier discounting, it supports durable demand and reduces the risk that prior pricing merely pulled sales forward. But brand reinvestment can absorb the benefit before it reaches earnings, so the Oct. 29 report should be judged on volume and margin direction together—not volume alone. Europe is the key falsifier.

Monster has a longer-duration growth case, with Coca-Cola’s distribution potentially extending reach; that may also benefit KO’s system economics, though the article provides no evidence on how much value accrues to KO versus Monster. The counterweight is that faster international expansion increases exposure to local regulation and execution, while aluminum pressure can offset revenue growth. The early-November report is a near-term catalyst, not proof of a multi-year trend.

KDP’s 2027 separation is a potential valuation catalyst, but leverage and weaker U.S. coffee demand make the allocation of debt, stranded costs, and standalone cash flows more important than the headline split. Until those details are clearer, a breakup discount can persist rather than close. Over 1–3 months, earnings and guidance dominate; over 6–18 months, KDP’s separation economics and MNST’s ability to translate overseas growth into profits matter most. The contrarian risk: a broad selloff may create entry points, but it does not make all three equally attractive or guarantee a rebound.

Key Decisions for Investors

• Prefer a modest, staged long in MDLZ ahead of Oct. 29 over buying all three indiscriminately. Add only if volume remains positive without margin deterioration; reduce or exit if Europe weakens or guidance indicates reinvestment is materially eroding profitability.
• Treat MNST as a watch/scale-in candidate around its early-November report, not a blind pre-earnings buy. Verify aluminum-cost commentary and whether international growth is converting to earnings; regulatory limits on sales or a reversal in overseas momentum falsify the thesis. KO is a possible indirect beneficiary, but quantify distribution economics before positioning it as a proxy.
• Wait for KDP’s Nov. 3 update before taking a breakup-value position. Require clearer debt allocation, standalone cost structure, and coffee-demand trends; the thesis weakens if leverage rises beyond the stated path or the separation timeline/economics become less credible.
• Avoid options or an equal-weight basket solely on the calendar catalyst: the reports create gap risk, and the article supplies no valuation or implied-volatility data to establish attractive event pricing.